HARMONY BIOSCIENCES HOLDINGS, INC. Preferred Shares: Authorized and Outstanding
The company's filed XBRL preferred stock facts (us-gaap Preferred*), one row per period end, newest first. Values are as filed.
- 2021-12-31: Preferred Stock, Par or Stated Value Per Share $0.00; Preferred Stock, Shares Authorized 10.00M shares; Preferred Stock, Shares Issued 0.00 shares; Preferred Stock, Shares Outstanding 0.00 shares.
- 2021-09-30: Preferred Stock, Par or Stated Value Per Share $0.00; Preferred Stock, Shares Authorized 10.00M shares; Preferred Stock, Shares Issued 0.00 shares; Preferred Stock, Shares Outstanding 0.00 shares.
- 2021-06-30: Preferred Stock, Par or Stated Value Per Share $0.00; Preferred Stock, Shares Authorized 10.00M shares; Preferred Stock, Shares Issued 0.00 shares; Preferred Stock, Shares Outstanding 0.00 shares.
- 2021-03-31: Preferred Stock, Par or Stated Value Per Share $0.00; Preferred Stock, Shares Authorized 10.00M shares; Preferred Stock, Shares Issued 0.00 shares; Preferred Stock, Shares Outstanding 0.00 shares.
| Period end | Preferred Stock, Par or Stated Value Per Share | Preferred Stock, Shares Authorized | Preferred Stock, Shares Issued | Preferred Stock, Shares Outstanding | Preferred Stock Dividends, Income Statement Impact |
|---|---|---|---|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-02-28 | 10.00M shares 10-K · filed 2022-02-28 | 0.00 shares 10-K · filed 2022-02-28 | 0.00 shares 10-K · filed 2022-02-28 | |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-09 | 10.00M shares 10-Q · filed 2021-11-09 | 0.00 shares 10-Q · filed 2021-11-09 | 0.00 shares 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-10 | 10.00M shares 10-Q · filed 2021-08-10 | 0.00 shares 10-Q · filed 2021-08-10 | 0.00 shares 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-11 | 10.00M shares 10-Q · filed 2021-05-11 | 0.00 shares 10-Q · filed 2021-05-11 | 0.00 shares 10-Q · filed 2021-05-11 | |
| 2020-12-31 | $0.00 10-K · filed 2022-02-28 | 0.00 shares 10-K · filed 2022-02-28 | 0.00 shares 10-K · filed 2022-02-28 | 0.00 shares 10-K · filed 2022-02-28 | $26.90M 10-K · filed 2023-02-21 |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-12 | 10.00M shares 10-Q · filed 2020-11-12 | 0.00 shares 10-Q · filed 2020-11-12 | 0.00 shares 10-Q · filed 2020-11-12 | $6.01M 10-Q · filed 2021-11-09 |
| 2020-06-30 | $10.45M 10-Q · filed 2021-08-10 | ||||
| 2020-03-31 | $10.45M 10-Q · filed 2021-05-11 | ||||
| 2019-12-31 | $0.00 10-K · filed 2021-03-25 | 0.00 shares 10-K · filed 2021-03-25 | 0.00 shares 10-K · filed 2021-03-25 | 0.00 shares 10-K · filed 2021-03-25 | $35.23M 10-K · filed 2022-02-28 |
| 2019-09-30 | $9.03M 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |